Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres Forero-Torres

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Current Treatment Options in Oncology|November 4, 2011
How do I treat "triple-negative" diseaseChristos Vaklavas, Andres Forero-Torres
Therapeutic Advances in Hematology|April 23, 2013
Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphomaChristos Vaklavas, Andres Forero-Torres
Current Oncology Reports|July 22, 2015
Development and Integration of Antibody-Drug Conjugate in Non-Hodgkin LymphomaAmitkumar Mehta, Andres Forero-Torres
Clinical Lymphoma & Myeloma|March 8, 2008
Bendamustine in non-Hodgkin lymphoma: the double-agent that came from the Cold WarAndres Forero-Torres, Mansoor N Saleh
Future Oncology (London, England)|July 31, 2007
TRAIL-receptor antibodies as a potential cancer treatmentDonald J Buchsbaum, Andres Forero-Torres, Albert F LoBuglio
The Surgical Clinics of North America|July 15, 2018
Future Developments in Neoadjuvant Therapy for Triple-Negative Breast CancerLakisha Moore-Smith, Andres Forero-Torres, Erica Stringer-Reasor
Leukemia & Lymphoma|December 30, 2009
A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemiaRichard R Furman, Andres Forero-Torres, Andrei Shustov, et al.
Ultrasound in Medicine & Biology|June 28, 2015
Ultrasound imaging of breast tumor perfusion and neovascular morphologyKenneth Hoyt, Heidi Umphrey, Mark Lockhart, et al.
Clinical Case Reports|June 8, 2017
Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemiaLauren K Shea, Fady M Mikhail, Andres Forero-Torres, et al.
Clinical Nuclear Medicine|August 18, 2004
Diffuse F-18 FDG uptake in skeletal muscles secondary to chills resulting from sepsis: a cause for underestimation of viable tumorBuddhiwardhan Ojha, Ashok Muthukrishnan, Arun Kumar Raman, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Current Treatment Options in Oncology|November 4, 2011
How do I treat "triple-negative" diseaseChristos Vaklavas, Andres Forero-Torres
Therapeutic Advances in Hematology|April 23, 2013
Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphomaChristos Vaklavas, Andres Forero-Torres
Current Oncology Reports|July 22, 2015
Development and Integration of Antibody-Drug Conjugate in Non-Hodgkin LymphomaAmitkumar Mehta, Andres Forero-Torres
Clinical Lymphoma & Myeloma|March 8, 2008
Bendamustine in non-Hodgkin lymphoma: the double-agent that came from the Cold WarAndres Forero-Torres, Mansoor N Saleh
Future Oncology (London, England)|July 31, 2007
TRAIL-receptor antibodies as a potential cancer treatmentDonald J Buchsbaum, Andres Forero-Torres, Albert F LoBuglio
The Surgical Clinics of North America|July 15, 2018
Future Developments in Neoadjuvant Therapy for Triple-Negative Breast CancerLakisha Moore-Smith, Andres Forero-Torres, Erica Stringer-Reasor
Leukemia & Lymphoma|December 30, 2009
A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemiaRichard R Furman, Andres Forero-Torres, Andrei Shustov, et al.
Ultrasound in Medicine & Biology|June 28, 2015
Ultrasound imaging of breast tumor perfusion and neovascular morphologyKenneth Hoyt, Heidi Umphrey, Mark Lockhart, et al.
Clinical Case Reports|June 8, 2017
Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemiaLauren K Shea, Fady M Mikhail, Andres Forero-Torres, et al.
Clinical Nuclear Medicine|August 18, 2004
Diffuse F-18 FDG uptake in skeletal muscles secondary to chills resulting from sepsis: a cause for underestimation of viable tumorBuddhiwardhan Ojha, Ashok Muthukrishnan, Arun Kumar Raman, et al.
Pageof 10